Amanda is a seasoned professional with nearly a decade of experience in the life sciences industry. Her expertise lies in partnering with organizations to drive commercial strategy and new product planning for pipeline therapies. Amanda is adept at portfolio prioritization, strategic planning and L&A, ensuring that companies can effectively navigate complex markets and maximize their impact.

Throughout her tenure at Trinity, Amanda has developed deep expertise across various therapeutic areas including neurology, psychiatry, immunology, and nephrology, contributing to large integrated projects across strategic advisory, primary market research and data analytics showcasing her ability to manage and support multifaceted initiatives.

Amanda earned a PharmD from Universidad de Navarra (Spain), a MS in Biotechnology from Georgetown University, and an MBA from Tuck School of Business at Dartmouth. Outside of her professional life, Amanda enjoys traveling and spending time outdoors with her husband, son and dog.